News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
101 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21249)
Month
January (2935)
February (2968)
March (2710)
April (2908)
May (3626)
June (2409)
July (2088)
August (2590)
September (2381)
October (3064)
November (3189)
December (2222)
Day
1 (95)
2 (82)
3 (84)
4 (29)
7 (42)
8 (100)
9 (111)
10 (103)
11 (62)
14 (67)
15 (76)
16 (101)
17 (95)
18 (54)
21 (65)
22 (91)
23 (150)
24 (98)
25 (112)
28 (70)
29 (128)
30 (120)
31 (153)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
7
8
9
10
11
14
15
16
17
18
21
22
23
24
25
28
29
30
31
Rare diseases
AstraZeneca’s Amyloidosis Asset Stumbles in Late-Stage Trials
The antibody anselamimab, which AstraZeneca picked up in its 2021 purchase of Caelum Biosciences, failed to improve survival and reduce hospitalizations, but the company sees promise in data from an unspecified patient subgroup.
July 16, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Imperative Care Presents Positive Imperative Trial Data from Patients Treated with Aspiration Thrombectomy for M2 Occlusions Using the Zoom System
July 16, 2025
·
3 min read
Press Releases
Perfuze Presents Preliminary Results from MARRS Pivotal Trial at SNIS, Highlighting Millipede88 Performance in Acute Ischemic Stroke
July 16, 2025
·
4 min read
Press Releases
Arthrex NanoScope™ System Receives Pediatric Clearance for Orthopedic, Laparoscopic Procedures
July 16, 2025
·
3 min read
Press Releases
RIVANNA’s next-generation ultrasound guidance platform and AI-driven imaging software receive FDA 510(k) clearance
July 16, 2025
·
3 min read
Press Releases
Prima Mente Launches Pleiades, a Large-Scale Human Whole-Epigenome Foundation Model with Clinical Applications for Alzheimer’s Disease
July 16, 2025
·
4 min read
Press Releases
Outset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
July 16, 2025
·
1 min read
Press Releases
Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025
July 16, 2025
·
1 min read
Press Releases
TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025
July 16, 2025
·
1 min read
Layoffs
Sarepta Tags DMD Gene Therapy Elevidys With Black Box Warning, Axes 500 Staff
Following the death of two teenage patients with Duchenne muscular dystrophy following Elevidys treatment, Sarepta Therapeutics adds a black box warning to the gene therapy for acute liver injury and failure and parts with more than a third of employees.
July 16, 2025
·
2 min read
·
Heather McKenzie
Previous
10 of 11
Next
